Initial Statement of Beneficial Ownership (3)
July 09 2019 - 5:01PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Hudson Thomas J
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
7/1/2019
|
3. Issuer Name
and
Ticker or Trading Symbol
AbbVie Inc. [ABBV]
|
(Last)
(First)
(Middle)
1 NORTH WAUKEGAN ROAD
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___
X
___ Officer (give title below)
_____ Other (specify below)
SVP, R&D and CSO /
|
(Street)
NORTH CHICAGO, IL 60064
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common stock, $0.01 par value
|
12748
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Option (right to buy)
|
(1)
|
5/22/2026
|
Common stock, $0.01 par value
|
14080
|
$59.50
|
D
|
|
Option (right to buy)
|
(2)
|
2/15/2027
|
Common stock, $0.01 par value
|
15230
|
$61.36
|
D
|
|
Option (right to buy)
|
(3)
|
2/14/2028
|
Common stock, $0.01 par value
|
6710
|
$114.36
|
D
|
|
Option (right to buy)
|
(4)
|
2/20/2029
|
Common stock, $0.01 par value
|
15576
|
$79.02
|
D
|
|
Explanation of Responses:
|
(1)
|
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 4,694 shares on 5/23/2017, as to 4,693 shares on 5/23/2018 and as to 4,693 shares on 5/23/2019.
|
(2)
|
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 5,077 shares on 2/16/2018 and as to 5,077 shares on 2/16/2019, and becomes exercisable as to 5,076 shares on 2/16/2020.
|
(3)
|
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 2,237 shares on 2/15/2019, and becomes exercisable as to 2,236 shares on 2/15/2020 and as to 2,237 shares on 2/15/2021.
|
(4)
|
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable as to 5,192 shares on 2/21/2020, as to 5,192 shares on 2/21/2021 and as to 5,192 shares on 2/21/2022.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Hudson Thomas J
1 NORTH WAUKEGAN ROAD
NORTH CHICAGO, IL 60064
|
|
|
SVP, R&D and CSO
|
|
Signatures
|
Steven L. Scrogham, attorney-in-fact for Thomas J. Hudson
|
|
7/9/2019
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Aug 2024 to Sep 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Sep 2023 to Sep 2024